Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is more common in men, linked to genetics and androgen levels, but routine pelvic ultrasound isn't recommended.

Hirsutism is relatively common among young Greek women.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Family history affects hair loss severity and onset more in men than women.

Androgenetic alopecia, or hair loss, is influenced by hormones and genetics, and can be treated with medications like minoxidil, finasteride, or hormone therapy, with effectiveness evaluated after 6 months.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.

Both hair transplantation and skin expansion are effective for treating cicatricial alopecia, with the best method depending on the patient's age, alopecia size, and other factors.

Orthognathic surgeons play a key role in modifying masculine facial features to be more feminine, often improving transgender women's quality of life.

The document concludes that understanding health requires considering evolutionary perspectives on reproductive fitness, and recognizing the complexity of factors like diet, testosterone, and sexual orientation.

Medical care for transgender youth should be individualized and supportive.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Baldness challenged men's self-image and masculinity in Britain from the late 19th to early 20th centuries, leading to a market for hair loss treatments.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

Finasteride effectively treats male hair loss, increasing length and thickness.

Hormonal therapy in transgender patients can lead to skin changes like altered sebum production, hair growth, and acne, which may require dermatological care.

The review discusses how facial masculinization surgeries are done and their costs.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Facial aesthetic procedures improve quality of life for transgender individuals.

Proper management of the dilation program is crucial after male-to-female reassignment surgery.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Living with lupus as both a patient and doctor improved understanding and care for others.

Videodermoscopy better identifies female hair loss than clinical diagnosis.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Uterine transplants for transgender women are feasible but need more research.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

HIV-1 may cause increased stem cell death in hair follicles, leading to hair loss.

Telogen effluvium is linked to deficiencies in iron, vitamin B12, and thyroid function.